Medical and Economic Long-term Effects of B-Type Natriuretic Peptide Testing in Patients with Acute Dyspnea - Concepedia

Concepedia

Publication | Open Access

Medical and Economic Long-term Effects of B-Type Natriuretic Peptide Testing in Patients with Acute Dyspnea

DOI Full Paper Access

51

Citations

29

References

2007

Year

Tobias Breidthardt, Kirsten Laule, Anne-Henny Strohmeyer, Christian Schindler, Sophie Meier, Michael A. Fischer, André Scholer, Markus Noveanu, Michael Christ, André P. Perruchoud,

Clinical Chemistry

Abstract

Rapid BNP testing in patients with acute dyspnea has no effect on long-term mortality. However, morbidity as quantified by days spent in-hospital and economic outcome are still improved at 360 days.

References

	Year	Citations
Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure Alan S. Maisel, Padma Krishnaswamy, Richard M. Nowak, New England Journal of Medicine	2002	3.3K
Recommendations of the Panel on Cost-Effectiveness in Health and Medicine Milton C. Weinstein JAMA	1996	2.4K
Guidelines for the diagnosis and treatment of chronic heart failure W. Remme European Heart Journal Heart FailureChronic Heart FailureStructural Heart DiseaseCardiovascular DiseaseCardiac Care	2001	1.6K
ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure) Sharon A. Hunt, David W. Baker, Marshall H. Chin, Circulation	2001	1.4K
Treatment of heart failure guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations Richard W. Troughton, Christopher Frampton, Timothy G. Yandle, The Lancet NeuropeptidesHeart FailureCardiovascular DiseaseNeurologyDiuretic Resistance	2000	1.4K
Recommendations for Reporting Cost-effectiveness Analyses Joanna E. Siegel JAMA Cost-effectiveness AnalysisProgram ImplementationHealth Care FinanceProgram EvaluationClinical Trials	1996	1.1K
Impact of Obesity on Plasma Natriuretic Peptide Levels Thomas J. Wang, Martin G. Larson, Daniel Levy, Circulation	2004	1K
Use of B-Type Natriuretic Peptide in the Evaluation and Management of Acute Dyspnea Christian Mueller, André Scholer, Kirsten Laule-Kilian, New England Journal of Medicine	2004	1K
Biochemical detection of left-ventricular systolic dysfunction T. McDonagh, SD Robb, J.J. Morton, The Lancet CardiomyopathyHeart FailureBiochemical DetectionCardiovascular DiseasePhysiology	1998	972
B-Type Natriuretic Peptide and Clinical Judgment in Emergency Diagnosis of Heart Failure Peter A. McCullough, Richard M. Nowak, James McCord, Circulation	2002	881

Page 1